Cartesian Therapeutics (RNAC) P/E (2016 - 2026)
Cartesian Therapeutics (RNAC) P/E from Jun 22, 2016 to Jul 21, 2026. The TTM Cartesian Therapeutics (RNAC) P/E is -1.43. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cartesian Therapeutics (RNAC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.43 | -0.88% |
| 2025 | -1.44 | -12.17% |
| 2024 | -1.64 | -44.10% |
| 2023 | -2.93 | -186.99% |
| 2022 | 3.37 | -124.20% |
| 2021 | -13.92 | +220.92% |
| 2020 | -4.34 | +92.51% |
| 2019 | -2.25 | -90.28% |
| 2018 | -23.19 | -72.88% |
| 2017 | -85.51 | -42.80% |
| 2016 | -149.49 | N/A |
Comparison Cartesian Therapeutics (RNAC) P/E with competitors
Cartesian Therapeutics (RNAC) P/E is -1.43.